Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
作者： Anthony Andrea Fossa
DOI:
关键词:
摘要: This invention is directed to pharmaceutical compositions comprising corticotropin releasing factor antagonist and growth hormone or secretagogues, prodrugs thereof, pharmaceutically acceptable salts of said compounds prodrugs. The also methods treating heart related diseases (including congestive failure) in mammals, particularly humans.
lens.org 参考文章(24)
Anthony A. Fossa, Use of CRF antagonists and renin-angiotensin system inhibitors ,(2000)
Ravi Nargund, 4-spiroindoline piperidines promote release of growth hormone ,(1997)
Anthony Andrea Fossa, Qt dispersion and heart rate variability improvement with crf antagonists to prevent sudden death ,(2000)
Ernest Seiichi Hamanaka, Yuhpyng Liang Chen, Use of corticotropin releasing factor antagonists and related compositions ,(2000)
Federico Maisano, Elisabetta Franchi, Silvia Astrua Testori, Guido Grandi, Method for the preparation of human growth hormone ,(1992)
John Hakkinen, Composition and methods for stimulating gastrointestinal motility ,(2001)
Yuhpyng L. Chen, Use of CRF antagonists to treat circadian rhythm disorders ,(2000)
Chaovanee Aroonsakul, Method of treatment for central nervous system diseases such as Alzheimer's's disease ,(1984)
Yuhpyng Liang Chen, Substituted 6,5-hetero-bicyclic derivatives ,(1997)
Danielle Gully, Pierre Roger, Camille Georges Wermuth, Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them Official Gazette of the United States Patent and Trademark Office Patents. ,vol. 1220, pp. 1564- ,(1996)